Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1286-1291

  Nakajima, Takako Eguchi ^a   Yamada, Yasuhide ^a   Hamano, Tetsutaro ^b   Furuta, Koh ^a   Matsuda, Takahisa ^a   Fujita, Shin ^a   Kato, Ken ^a   Hamaguchi, Tetsuya ^a   Shimada, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b Hamano Statistical Analysis Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C PEPTIDE; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TUMOR MARKER;

ADULT; ARTICLE; BODY MASS; CANCER GROWTH; CANCER STAGING; CLINICAL EVALUATION; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADENOMA; ADIPOKINES; ADIPONECTIN; ADULT; AGED; BODY MASS INDEX; C-PEPTIDE; COLORECTAL NEOPLASMS; CYTOKINES; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 77953217397     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01518.x     Document Type: Article

References (37)

1. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004, 24:29-33.
2. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004, 5:153-65.
3. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004, 23:6365-78.
4. Nishii T, Kono S, Abe H. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese men. Jpn J Cancer Res 2001, 92:836-40.
5. Wolk A, Gridley G, Svensson M. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001, 12:13-21.
6. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-808.
7. Xu H, Barnes GT, Yang Q. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-30.
8. Fain JN, Leffler CW, Cowan GS, Buffington C, Pouncey L, Bahouth SW. Stimulation of leptin release by arachidonic acid and prostaglandin E(2) in adipose tissue from obese humans. Metabolism 2001, 50:921-8.
9. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004, 431:405-6.
10. Fenton JI, Hord NG, Lavigne JA, Perkins SN, Hursting SD. Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev 2005, 14:1646-52.
11. Park HY, Kwon HM, Lim HJ. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001, 33:95-102.
12. Zhao X, Huang K, Zhu Z, Chen S, Hu R. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer. J Gastroenterol Hepatol 2007, 22:1317-21.
13. Nakajima TE, Yamada Y, Hamano T. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 2009, 44:685-90.
14. Petridou E, Mantzoros C, Dessypris N. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003, 88:993-7.
15. Miyoshi Y, Funahashi T, Kihara S. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003, 9:5699-704.
16. Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D. Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 2000, 11:383-8.
17. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology 2005, 65:1168-72.
18. Hsing AW, Chua S, Gao YT. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001, 93:783-9.
19. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005, 97:1688-94.
20. Stattin P, Lukanova A, Biessy C. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004, 109:149-52.
21. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009, 24:275-81.
22. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-9. quiz 20
23. Kumada M, Kihara S, Ouchi N. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004, 109:2046-9.
24. Yokota T, Oritani K, Takahashi I. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-32.
25. Wang Y, Lam KS, Xu JY. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005, 280:18341-7.
26. Ferroni P, Palmirotta R, Spila A. Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res 2007, 27:483-9.
27. Otake S, Takeda H, Suzuki Y. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005, 11:3642-6.
28. Sierra-Honigmann MR, Nath AK, Murakami C. Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-6.
29. Chia VM, Newcomb PA, Lampe JW. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007, 16:2697-703.
30. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001, 121:79-90.
31. Nakajima TE, Yamada Y, Hamano T. Adipocytokines and squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol 2010, 136:261-6.
32. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450-7.
33. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-9.
34. Dalamaga M, Karmaniolas K, Nikolaidou A. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system. Eur J Cancer 2008, 44:1744-53.
35. Dalamaga M, Karmaniolas K, Panagiotou A. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Cancer Causes Control 2009, 20:193-9.
36. Tilg H, Moschen AR. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond) 2008, 114:275-88.
37. Hufton SE, Moerkerk PT, Brandwijk R, de Bruine AP, Arends JW, Hoogenboom HR. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 1999, 463:77-82.